What are the risks of neonatal jaundice for babies? Neonatal jaundice is a yellowing of the skin, mucous membranes or tissues and organs caused by excessive accumulation of bilirubin in newborns, and can occur in 60% of full-term infants and 80% of premature infants. The incidence, peak value and factors affecting neonatal jaundice vary from region to region, such as individual differences in newborns, race, region, genetics, maternal factors, feeding methods, delivery methods and other factors can affect the degree of neonatal jaundice, and if neonatal jaundice is not treated in a timely manner, the toxicity of bilirubin can cause permanent damage to the nervous system or even If left untreated, the toxicity of bilirubin can cause permanent neurological damage or even death. What are the clinical treatments for neonatal jaundice? In recent years, with the popularization of breastfeeding, the incidence of neonatal jaundice has shown an increasing trend. We know that the prevention and treatment of neonatal jaundice is a shared responsibility between neonatology, obstetrics, community health workers and parents. The aim of neonatal jaundice treatment is to reduce serum bilirubin levels and prevent the occurrence of bilirubin encephalopathy, especially during the first week of life.
Serum bilirubin levels should be closely monitored within the first week of life and treated promptly when intervention criteria are met. If neonatal jaundice reaches the standard of phototherapy, add phototherapy on the basis of Yinjianhuang oral solution, and the two are applied jointly to shorten the treatment time, and the clinical application is safe. When the serum bilirubin level is close to the blood exchange value, and the albumin level is 25g/L,
If neonatal jaundice meets the criteria for blood exchange, blood exchange therapy can be used to exchange out the bilirubin, antibodies and allergenic red blood cells. What are the current problems with neonatal jaundice? A large number of studies have shown that the lack of awareness of the dangers of jaundice, the lack of attention and the lack of effective follow-up measures are important reasons for the serious dangers of neonatal jaundice. The results of epidemiological surveys done in northeast, north and south China show that the peak of bilirubin level in our newborns is day 4-5 of the newborn’s age. However, it has become common for newborns in China to be discharged from hospital within 3 days after birth.
However, it has become common for newborns to be discharged from hospital within 3 days after birth. The disadvantage of early discharge is that the serum bilirubin level has not yet reached its peak when the newborn is discharged from the hospital, parents do not have sufficient knowledge of neonatal jaundice, and the lack of light in the room where the mother rests after delivery in China leads to insufficient observation of the yellow staining of the newborn’s skin, which often occurs when we consider a “healthy” full-term newborn returns to the outpatient clinic or emergency room. The severe hyperbilirubinemia of the newborn has already formed hyperbilirubin encephalopathy, which has lost the best time for treatment and caused irreparable damage to parents and society. It is recommended that parents of newborns should be given more knowledge and education, and when the newborn is discharged from the hospital, the hospital should provide a written bilirubin monitoring plan and make regular return visits or follow-up visits. Parents should closely observe the situation of newborns, and if they find that their babies have mild jaundice at home, they can choose Yin Gardenia Huang oral solution for prevention and treatment, and most babies’ jaundice will subside after five days of taking it. If you find that your baby’s jaundice continues to worsen you should go to the hospital as soon as possible.